Queen Mary University of London
Prognostic Factors in Prostate Cancer for Patients Treated by Watchful Waiting, conducted by the Transatlantic Prostate Group (TAPG) is a long-term retrospective epidemiology cohort study on factors predicting clinical progression of prostate cancer. The TAPG study started in 1999 and comprises approximately 3,300 men diagnosed with prostate cancer between 1990 and 2006. This exploratory study aims to identify prognostic markers that will more accurately predict the probability of recurrence and allow for better patient selection for radical treatment of prostate cancer.
- Carcinoma in situ of prostate (disorder)
Centre for Cancer Prevention
Wolfson Institute of Preventive Medicine
Last Updated: 23/04/2019
|Year||Access Requests Received||Access Requests Approved|